XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Cash Flows - USD ($)
10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Cash Flows From Operating Activities:    
Net income (loss) $ (3,578,400) $ 12,018,933
Adjustments to reconcile net income to net cash used in operating activities:    
Investment income earned on treasury securities held in the Trust Account (6,966) (2,435,899)
Costs associated with warrant liabilities 735,630 0
Gain on change in fair value of derivative liabilities (5,244,100) (12,308,900)
Gain on change in fair value of note payable – Sponsor 0 (564,848)
Share-based compensation 6,217,250 0
Changes in operating assets and liabilities:    
Prepaid expenses (294,062) 28,747
Accounts payable and accrued expenses 1,373,309 1,146,284
Net Cash Used In Operating Activities (797,339) (2,115,683)
Cash Flows From Investing Activities:    
Cash deposited into the Trust Account (169,000,000) 0
Net Cash Used In Investing Activities (169,000,000) 0
Cash Flows From Financing Activities:    
Sale of Units in the Initial Public Offering, net of underwriting discount 165,620,000 0
Sale of Private Placement Warrants to the Sponsor 6,380,000 0
Proceeds from note payable – Sponsor 0 600,000
Proceeds from related party advances 27,250 2,040
Repayment of related party advances 0 (28,844)
Payment of offering costs (660,108) 0
Net Cash Provided By Financing Activities 171,367,142 573,196
Net change in cash 1,569,803 (1,542,487)
Cash at beginning of year 0 1,569,803
Cash at end of year 1,569,803 27,316
Supplemental disclosure of non-cash financing activities:    
Deferred offering costs paid by Sponsor in exchange for Class B ordinary shares 25,000 0
Supplemental disclosure of non-cash financing activities:    
Initial classification of fair value of warrants 20,910,300 0
Measurement adjustment of Class A ordinary shares to redemption value 169,000,000 0
Deferred underwriting compensation charged to additional paid-in capital in connection with the Initial Public Offering 5,915,000 0
Deferred offering costs paid by Sponsor 73,297 0
Measurement adjustment of carrying value to redemption value $ 0 $ 2,442,865